CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms

Clinical Cytometry

Volumn 50, Issue 5, 2002, Pages 243-248

  Kingma, Douglas W ^a   Imus, Paula ^a   Xie, Xiu Y ^a   Jasper, Gregory ^a   Sorbara, Lynn ^a   Stewart, Carleton ^b   Stetler Stevenson, Maryalice ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

B cell lymphoma; CD2; Flow cytometry; Leukemia

Indexed keywords

CD2 ASSOCIATED PROTEIN; CD2 ANTIGEN; TUMOR MARKER;

ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; CELL MATURATION; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; FOLLICLE CENTER LYMPHOMA; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; DISEASE COURSE; HISTIOCYTIC LYMPHOMA; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; PATHOPHYSIOLOGY; REFERENCE VALUE; RETROSPECTIVE STUDY; ANTIGEN EXPRESSION; BONE MARROW CELL; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;

ANTIGENS, CD2; B-LYMPHOCYTES; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, HAIRY CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOID TISSUE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, MANTLE-CELL; REFERENCE VALUES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0037107770     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10131     Document Type: Article

References (24)

1. Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 1984;63:1424-1433.
2. Uckun FM. Regulation of B cell ontogeny. Blood 1990;76:1908-1923.
3. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right angle light scatter to gate on leukemic blasts in three color analysis. Am J Clin Pathol 1993;100:534-540.
4. Stetler-Stevenson M, Braylan RC. Flow cytometric analysis of lymphomas and lymphoproliferative disorders. Semin Hematol 2001;38:111-123.
5. Kamoun M, Martin PJ, Hansen JA, Brown MA, Siadak AW, Norwinski RC. Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med 1981;153:207-304.
6. Van Wauwe J, Goossens J, Decock W, Kung P, Goldstein G. Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A. Immunology 1981;131:611-619.
7. Duan XC, Kabelitz D. Stimulation of CD2-negative T-cells by staphylococcal-enterotoxin-superantigens. Immunol Lett 1991;29:219-222.
8. Dustin ML, Springer T. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991;9:27-66.
9. Punnonen J, de Vries JE. Characterization of a novel CD2+ human thymic B cell subset. J Immunol 1993;151:100-110.
10. Fukushima P, Nguyen P, O'Grady P, Stetler-Stevenson M. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry 1996;26:243-252.
11. Schmidt CJ, Domenico L, Ward P, Barcos MP, Stweart CC. Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas. Leukemia Lymphoma 1999;34:539-544.
12. Segal GH, Jorgensen T, Scott M, Braylan RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: follicular lymphomas. Hum Pathol 1994;25:1276-1282.
13. McCarthy K, Sloane JP, Kabarowski JHS, Matutes E, Wiedermann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol 1992;1:173-179.
14. Dunphy CH, Chu J. Aberrant CD2 expression in precursor-B acute lymphoblastic leukemia of childhood. Am J Hematol 1996;52:224-226.
15. Uckun FM, Muraguchi A, Ledbetter JA, Kishimoto T, O'Brien RT, Roloff JS, Gajl-Peczalska K, Provisor A, Koller B. Biphenotypic leukemic lymphocyte precursors in CD2+CD19- acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 1989;73:1000-1015.
16. Cantu-Rajnoldi A, Putti MC, Schiro R, Biondi A, Cattoretti G, Valeggio C, Castagni M, Basso G. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-Rosette co-expression. Haematologica 1992;77:384-391.
17. Yagita H, Nakamura T, Asakawa J, Matsuda H, Tansyo S, Yutaka I, Okumura K. CD2 expression in murine B cell lineage. Int Immunol 1989;1:94-98.
18. Guglielmi P, Preud'homme JL, Brouet JC. Erythrocyte-rosette receptor expression by chronic lymphocytic leukemia B lymphocytes. Eur J Immunol 1983;13:641-646.
19. Catovsky D, Foa R, editors. The lymphoid leukaemias. London: Butterworths; 1990.
20. Viciana AL, Lancet FC, Chamizo W, Voigt W, Ruiz P. Simultaneous expression of CD2 on a B-cell, small lymphocytic neoplasm. Cytometry 1994;18:42-48.
21. Brohee D, Cauchie P, Neve P. Co-expression of CD2 or CD8 antigens in B cell chronic lymphocytic leukemia. Acta Clin Belg 1994;49:183-186.
22. Kurosawa M, Machii T, Kitani T, Tokumine Y, Kawa K, Maekawa I, Kawamura T, Miyake T, Kanda M. HTLV-I associated myelopathy (HAM) after blood transfusion in a patient with CD2+ hairy cell leukemia. Am J Clin Pathol 1991;95:72-76.
23. Stetler-Stevenson M. Novel methods in detection of minimal residual non-Hodgkin's lymphoma. Cytotherapy 1999;1:336-334.
24. Stetler-Stevenson M, Medeiros LJ, Jaffe ES. Immunophenotypic methods and findings in the diagnosis of lymphoproliferative diseases. In: Jaffe ES, editor. Surgical pathology of the lymph nodes and related organs. Philadelphia: W.B. Saunders; 1995. p 22-58.